DocMorris AG reports Q2 results; reaffirms FY outlook

* DocMorris AG press release [https://ir-corporate.docmorris.com/en/news/docmorris-increases-rx-revenue-by-over-40-per-cent-in-the-first-half-of-the/eff19321-e949-4a4b-ad18-c1871e1b6b5f] (OTCPK:ZRSEF [https://seekingalpha.com/symbol/ZRSEF]): Q2 Revenue of CHF 275.5M (+2.9% Y/Y).
* The number of active customers rose from 10.3 million to 10.5 million in the first half of the year, with a significant increase in the number of new Rx customers.
* Adjusted EBITDA amounted to minus CHF 28.8 million in the first half of the year.

*
Outlook

* Based on developments to date, management confirms the revenue and earnings guidance for 2025 and the medium-term targets announced on 10 April.

MORE ON DOCMORRIS AG

* Historical earnings data for DocMorris AG [https://seekingalpha.com/symbol/ZRSEF/earnings]
* Financial information for DocMorris AG [https://seekingalpha.com/symbol/ZRSEF/income-statement]